Cover Image

An innovative strategy to investigate microbial protein modifications in a reliable fast and sensitive way: A therapy oriented proof of concept based on UV-C irradiation of SARS-CoV-2 spike protein

The characterization of modifications of microbial proteins is of primary importance to dissect pathogen lifecycle mechanisms and could be useful in identifying therapeutic targets. Attempts to solve this issue yielded only partial and non-exhaustive results. We developed a multidisciplinary approac...

Full description

Saved in:

Bibliographic Details
Main Authors:	Sergio Strizzi (Author), Letizia Bernardo (Author), Pasqualina D'Ursi (Author), Chiara Urbinati (Author), Andrea Bianco (Author), Fiona Limanaqi (Author), Andrea Manconi (Author), Maria Milanesi (Author), Alberto Macchi (Author), Dario Di Silvestre (Author), Adalberto Cavalleri (Author), Giovanni Pareschi (Author), Marco Rusnati (Author), Mario Clerici (Author), PierLuigi Mauri (Author), Mara Biasin (Author)
Format:	Book
Published:	Elsevier, 2023-08-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Coronavirus spike protein-based vaccines. Vaccine delivery systems
by: Akmal M. Asrorov, et al.
Published: (2024)

Spike protein of SARS-CoV-2 Omicron variant: An in-silico study evaluating spike interactions and immune evasion
by: Jose A. Jimenez Ruiz, et al.
Published: (2022)

Rapid emergence of omicron sublineages expressing spike protein R346T
by: Ramona Groenheit, et al.
Published: (2023)

Potential antiviral peptides targeting the SARS-CoV-2 spike protein
by: Ibrahim Khater, et al.
Published: (2022)

Genetic diversity of MERS-CoV spike protein gene in Saudi Arabia
by: Sayed S. Sohrab, et al.
Published: (2020)

Assessment of immunoglobin G (spike and nucleocapsid protein) response to COVID-19 vaccination in Palestine
by: Imad Asmar, et al.
Published: (2023)

Using the spike protein feature to predict infection risk and monitor the evolutionary dynamic of coronavirus
by: Xiao-Li Qiang, et al.
Published: (2020)

Histamine Potentiates SARS-CoV-2 Spike Protein Entry Into Endothelial Cells
by: Somasundaram Raghavan, et al.
Published: (2022)

Mulberrofuran G, a Potent Inhibitor of SPIKE Protein of SARS Corona Virus 2
by: Fatemeh Sadat Hosseini, et al.
Published: (2021)

Broad-Spectrum Small-Molecule Inhibitors of the SARS-CoV-2 Spike-ACE2 Protein-Protein Interaction from a Chemical Space of Privileged Protein Binders
by: Sung-Ting Chuang, et al.
Published: (2022)

Targeting novel coronavirus SARS-CoV-2 spike protein with phytoconstituents of Momordica charantia
by: Santosh Kumar Singh, et al.
Published: (2021)

Cryptococcal proteases exhibit the potential to activate the latent SARS-CoV-2 spike protein
by: Nozethu Mjokane, et al.
Published: (2024)

Evaluation of Glutathione in Spike Protein of SARS-CoV-2 Induced Immunothrombosis and Cytokine Dysregulation
by: Brandon Norris, et al.
Published: (2024)

Production of spike and nucleocapsid recombinant proteins of porcine epidemic diarrhea virus for antibody detection by ELISA
by: Anchalee Srijangwad, et al.
Published: (2016)

Design of an epitope-based peptide vaccine against spike protein of human coronavirus: an in silico approach
by: Oany AR, et al.
Published: (2014)

The Modulation of Cholesterol Metabolism Is Involved in the Antiviral Effect of Nitazoxanide
by: Claudio Fenizia, et al.
Published: (2021)

Coronil, a Tri-Herbal Formulation, Attenuates Spike-Protein-Mediated SARS-CoV-2 Viral Entry into Human Alveolar Epithelial Cells and Pro-Inflammatory Cytokines Production by Inhibiting Spike Protein-ACE-2 Interaction
by: Balkrishna A, et al.
Published: (2021)

Bioinformatics prediction of B and T cell epitopes within the spike and nucleocapsid proteins of SARS-CoV2
by: Reham M. Dawood, et al.
Published: (2021)

Novel Small-Molecule Inhibitors of the SARS-CoV-2 Spike Protein Binding to Neuropilin 1
by: Anja Kolarič, et al.
Published: (2022)

Spike protein of SARS-CoV-2 suppresses gonadotrophin secretion from bovine anterior pituitaries
by: Dimas Arya ABDILLAH, et al.
Published: (2022)

Editorial: Toxic Plant Proteins as Experimental Drugs for Human Pathologies
by: Letizia Polito, et al.
Published: (2021)

A Repurposed Drug Screen Identifies Compounds That Inhibit the Binding of the COVID-19 Spike Protein to ACE2
by: Kaleb B. Tsegay, et al.
Published: (2021)

Clinical development of SpikoGen®, an Advax-CpG55.2 adjuvanted recombinant spike protein vaccine
by: Nikolai Petrovsky
Published: (2024)

SARS-CoV-2 spike protein-, main protease- and papain-like-protease-targeting peptides from seed proteins following gastrointestinal digestion: An in silico study
by: Fai-Chu Wong, et al.
Published: (2021)

Thrombospondin-1 as a Paradigm for the Development of Antiangiogenic Agents Endowed with Multiple Mechanisms of Action
by: Marco Rusnati, et al.
Published: (2010)

Postbiotic Preparation of <i>Lacticaseibacillus rhamnosus GG</i> against Diarrhea and Oxidative Stress Induced by Spike Protein of SARS-CoV-2 in Human Enterocytes
by: Marco Poeta, et al.
Published: (2023)

Characterization of SARS-CoV-2 worldwide transmission based on evolutionary dynamics and specific viral mutations in the spike protein
by: Jiluo Liu, et al.
Published: (2021)

Kaempferia parviflora Wall. ex Baker against SARS-CoV-2 spike protein: In silico and in vitro studies
by: Suhaina Supian, et al.
Published: (2024)

The Effect of Carthamus tinctorius in Combination with Dexamethasone on Coagulation Markers in Mice Induced by SARS-CoV2 Spike Protein
by: Yantirta Kurniawan, et al.
Published: (2023)

Immunogenicity of intranasal vaccine based on SARS-CoV-2 spike protein during primary and booster immunizations in mice
by: Huijie Yang, et al.
Published: (2024)

In Silico Study for Similar FDA Approved Drugs as Inhibitors of SARS-CoV-2 Spike and the Host Receptor Proteins
by: Israa Mohamed Shamkh, et al.
Published: (2021)

Lactoferrin Binds through Its N-Terminus to the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein
by: Patrik Babulic, et al.
Published: (2024)

The Screening of Broadly Neutralizing Antibodies Targeting the SARS-CoV-2 Spike Protein by mRNA Immunization in Mice
by: Zhiyin An, et al.
Published: (2023)

Glyceraldehyde-3-Phosphate Dehydrogenase Binds with Spike Protein and Inhibits the Entry of SARS-CoV-2 into Host Cells
by: Rahul Dilawari, et al.
Published: (2024)

Methylene Blue Inhibits the SARS-CoV-2 Spike-ACE2 Protein-Protein Interaction-a Mechanism that can Contribute to its Antiviral Activity Against COVID-19
by: Damir Bojadzic, et al.
Published: (2021)

Merging the Multi-Target Effects of Phytochemicals in Neurodegeneration: From Oxidative Stress to Protein Aggregation and Inflammation
by: Fiona Limanaqi, et al.
Published: (2020)

SARS-CoV-2 spike-protein targeted serology test results and their association with subsequent COVID-19-related outcomes
by: Harvey W. Kaufman, et al.
Published: (2023)

SARS-CoV-2 spike protein and RNA dependent RNA polymerase as targets for drug and vaccine development: A review
by: Yusuf Muhammed, et al.
Published: (2021)

SARS-CoV-2 spike protein accelerates systemic sclerosis by increasing inflammatory cytokines, Th17 cells, and fibrosis
by: Ha Yeon Jeong, et al.
Published: (2023)

Comprehensive engineering of a therapeutic neutralizing antibody targeting SARS-CoV-2 spike protein to neutralize escape variants
by: Taichi Kuramochi, et al.
Published: (2022)